好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Common Carotid Artery Pseudoaneurysm After Stent Placement for Symptomatic Carotid Web: Case Report and Updated Systematic Review of the Literature
Cerebrovascular Disease and Interventional Neurology
P3 - Poster Session 3 (5:00 PM-6:00 PM)
5-019
To describe a case of common carotid pseudoaneurysm following internal carotid artery stenting for a carotid web and provide an updated systematic review of published cases.
Common carotid artery pseudoaneurysm is a rare but serious complication following carotid artery stenting. Presentations range from asymptomatic neck masses on imaging to ischemic events, and management remains challenging.
A systematic review was performed in accordance with PRISMA guidelines. PubMed, Embase, and Scopus were searched from inception through September 2025 for human cases of carotid artery pseudoaneurysm after stenting.

We report a 56-year-old man with recurrent ischemic strokes due to a right carotid web unresponsive to conservative management. He underwent elective right internal carotid artery stenting with an open-cell stent without complications. Four months later, he presented with a pulsatile right-sided neck mass, diagnosed as a common carotid artery pseudoaneurysm at the proximal stent margin. His hospital course was complicated by methicillin-susceptible Staphylococcus aureus bacteremia treated by intravenous antibiotics, but an extensive workup excluded an infectious role in pseudoaneurysm formation. The lesion was treated with a balloon-expandable covered stent, achieving exclusion from circulation and thrombosis, exhibiting durable clinical and radiographic resolution. Connective tissue genetic testing is pending.

Systematic review identified fifteen cases of carotid pseudoaneurysm after stenting. Contributing factors included infection, prior irradiation or surgery, vessel fragility, and procedural trauma. Most involved closed cell stents, although open cell designs were also implicated. Surgical repair was favored for infected lesions, while endovascular approaches, including covered stents and flow diversion, were commonly used in noninfected cases with good outcomes.

Carotid artery pseudoaneurysm is a rare complication of stenting with diverse etiologies, including infection, connective tissue disorders, and prior radiation. Optimal management is individualized, integrating clinical presentation, neurological risk, and vascular anatomy. Both surgical and endovascular strategies can achieve favorable outcomes when tailored to patient-specific factors.

Authors/Disclosures
Nikhil Vj, Student
PRESENTER
Mr. Vj has nothing to disclose.
Pichatorn Suppakitjanusant, MD (Texas Tech University Health Sciences) Pichatorn Suppakitjanusant, MD has nothing to disclose.
Sunil Sheth, MD (University of Texas At Houston) Dr. Sheth has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Penumbra. Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerenovus. Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Imperative Care.
Robert W. Regenhardt, MD, PhD Dr. Regenhardt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genomadix. Dr. Regenhardt has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Rapid Medical. Dr. Regenhardt has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Johnson and Bell Trial Lawyers. Dr. Regenhardt has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Buckley, Theroux, Kline, & Cooley Trial Lawyers. The institution of Dr. Regenhardt has received research support from National Institutes of Health. The institution of Dr. Regenhardt has received research support from Society of Vascular and Interventional Neurology. The institution of Dr. Regenhardt has received research support from Heitman Foundation.
Michael Nahhas, MD (UTHealth Neurosciences Houston - Texas Medical Center) Dr. Nahhas has nothing to disclose.